Loading
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (30 ops.)
Latest filing published 24 Sept 2026 for Skye Bioscience, Inc., €40k.
Filing timeline
BuySaleAndrew J. Schwab
Insider track record
Disclosed buys
2
Disclosed sells
30
Signal history
Closed purchases
Market purchases
2
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Andrew J. Schwab: trading record in brief
This profile gathers the share dealings of Andrew J. Schwab across 6 companies, led by Skye Bioscience, Inc., Camp4 Therapeutics Corp and Pear Therapeutics, Inc. Between 26 May 2020 and 23 September 2026, the trades on record add up to 51 filings.
In open-market terms, that means 2 purchases worth €13.7M on one side and 30 sales worth €4.8M on the other. Netting one side against the other leaves €8.9M of net buying. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 14 share grants. So far in 2026, the count stands at no purchases and 20 sales.
On 24 September 2026 came the latest disclosure, an open-market sale for €40k in Skye Bioscience, Inc. The latest purchase dates back some time: it was published 738 days ago, on 15 October 2024. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Andrew J. Schwab
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations24 total
27,612 shares@ US$1.650.61% mcap0.2% of flowCommon StockSEC:0001598549-26-000015:0
1,088 shares@ US$1.650.024% mcap0.0% of flowCommon StockSEC:0001598549-26-000015:1
114,851 shares@ US$1.612.49% mcap0.9% of flowCommon StockSEC:0001598549-26-000015:2
4,528 shares@ US$1.610.098% mcap0.0% of flowCommon StockSEC:0001598549-26-000015:3
32,607 shares@ US$1.910.83% mcap0.3% of flowCommon StockSEC:0001598549-26-000013:0
1,285 shares@ US$1.910.033% mcap0.0% of flowCommon StockSEC:0001598549-26-000013:1
400,000 shares@ US$4.040.68% mcap23.2% of flowCommon StockSEC:0001598549-26-000011:0
10 shares@ US$4.500.0000% mcap0.0% of flowCommon StockSEC:0001598549-26-000009:0
45,147 shares@ US$4.760.090% mcap3.1% of flowCommon StockSEC:0001598549-26-000007:0
114,700 shares@ US$4.540.22% mcap7.5% of flowCommon StockSEC:0001598549-26-000007:1
32,018 shares@ US$4.500.060% mcap2.1% of flowCommon StockSEC:0001598549-26-000007:2
409 shares@ US$0.350.0019% mcap0.0% of flowCommon StockSEC:0001598549-26-000005:4
6,495 shares@ US$0.320.027% mcap0.0% of flowCommon StockSEC:0001598549-26-000005:8
45,090 shares@ US$0.380.23% mcap0.1% of flowCommon StockSEC:0001598549-26-000005:0
1,830 shares@ US$0.380.0092% mcap0.0% of flowCommon StockSEC:0001598549-26-000005:1
253,080 shares@ US$0.381.28% mcap0.5% of flowCommon StockSEC:0001598549-26-000005:2
10,255 shares@ US$0.350.048% mcap0.0% of flowCommon StockSEC:0001598549-26-000005:3
57,476 shares@ US$0.350.27% mcap0.1% of flowCommon StockSEC:0001598549-26-000005:5
1,159 shares@ US$0.320.0049% mcap0.0% of flowCommon StockSEC:0001598549-26-000005:6
46 shares@ US$0.320.0002% mcap0.0% of flowCommon StockSEC:0001598549-26-000005:7
2,941,176 shares@ US$1.5364.2% of flowCommon StockSEC:0001598549-25-000004:0
163,979 shares@ US$3.422.7% of flowCommon StockSEC:0001415889-25-022808:2
2,314 shares@ US$3.570.0% of flowCommon StockSEC:0001415889-25-022808:1
6,470 shares@ US$3.420.1% of flowCommon StockSEC:0001415889-25-022808:3
58,642 shares@ US$3.571.1% of flowCommon StockSEC:0001415889-25-022808:0
25 of 24 declarations
